(SLDB) Solid Biosciences - Performance -71.7% in 12m
Compare SLDB with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-88.37%
#156 in Group
Rel. Strength
8.37%
#7291 in Universe
Total Return 12m
-71.69%
#126 in Group
Total Return 5y
-92.95%
#117 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -48.10%
32th Percentile in Group
12m Total Return: SLDB (-71.7%) vs XBI (-14.9%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: SLDB vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SLDB
Total Return (including Dividends) | SLDB | XBI | S&P 500 |
---|---|---|---|
1 Month | 2.22% | 2.77% | 5.69% |
3 Months | -16.36% | -14.21% | -6.49% |
12 Months | -71.69% | -14.88% | 9.72% |
5 Years | -92.95% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | SLDB | XBI | S&P 500 |
1 Month | 41.8% | 57% | 89.4% |
3 Months | -68.4% | -82.3% | -72% |
12 Months | -85.7% | -53.1% | 49.3% |
5 Years | -82.0% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #56 | -0.53% | -3.28% |
3 Month | #9 | -2.51% | -10.6% |
12 Month | #125 | -66.7% | -74.2% |
5 Years | #118 | -90.4% | -96.6% |
FAQs
Does SLDB Solid Biosciences outperforms the market?
No,
over the last 12 months SLDB made -71.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months SLDB made -16.36%, while XBI made -14.21%.
Over the last 3 months SLDB made -16.36%, while XBI made -14.21%.
Performance Comparison SLDB vs Indeces and Sectors
SLDB vs. Indices SLDB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -34.9% | -3.47% | -48.8% | -81.4% |
US NASDAQ 100 | QQQ | -35.2% | -5.17% | -49.2% | -82.5% |
US Dow Jones Industrial 30 | DIA | -34.8% | -0.45% | -47.7% | -77.9% |
German DAX 40 | DAX | -35.4% | -12.8% | -74.4% | -96.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | -35.1% | -0.66% | -48.0% | -78.0% |
Hongkong Hang Seng | HSI | -37.8% | -12.7% | -58.3% | -79.9% |
India NIFTY 50 | INDA | -31.2% | -0.99% | -50.7% | -73.7% |
Brasil Bovespa | EWZ | -37.9% | -9.40% | -58.0% | -65.4% |
SLDB vs. Sectors SLDB is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -34.3% | -4.26% | -55.0% | -92.1% |
Consumer Discretionary | XLY | -36.3% | -4.47% | -46.6% | -86.5% |
Consumer Staples | XLP | -34.0% | 1.52% | -55.7% | -78.9% |
Energy | XLE | -37.2% | -2.27% | -42.8% | -62.7% |
Financial | XLF | -35.6% | -4.62% | -54.7% | -93.2% |
Health Care | XLV | -30.8% | 5.28% | -43.5% | -65.7% |
Industrial | XLI | -35.8% | -6.09% | -49.8% | -82.1% |
Materials | XLB | -35.1% | -2.82% | -44.7% | -65.6% |
Real Estate | XLRE | -34.1% | -4.69% | -51.2% | -85.3% |
Technology | XLK | -35.7% | -7.49% | -46.5% | -77.8% |
Utilities | XLU | -35.6% | -2.92% | -56.5% | -87.7% |
Aerospace & Defense | XAR | -35.1% | -6.95% | -58.1% | -97.7% |
Biotech | XBI | -27.2% | -0.55% | -27.7% | -56.8% |
Homebuilder | XHB | -34.5% | -3.39% | -35.1% | -62.8% |
Retail | XRT | -35.0% | -3.92% | -42.5% | -65.4% |